Stock Track | INSILICO Soars 5% in Intraday Trading Following Successful HKEX IPO

Stock Track2025-12-31

Insilico Medicine (03696.HK) saw its stock price surge by 5.00% during intraday trading on Wednesday, reflecting strong investor enthusiasm following its successful listing on the Hong Kong Stock Exchange (HKEX). The IPO, the largest biotech offering on HKEX in 2025, has positioned the company as a leader in AI-driven drug discovery.

The company's shares opened at HK$35.00, significantly above its issue price of HK$24.05, signaling robust market confidence. Insilico Medicine's innovative Pharma.AI platform and partnerships with top pharmaceutical firms, including Sanofi and Lilly, have further bolstered investor sentiment. The IPO has provided the company with additional resources to advance its mission of leveraging AI for faster and more efficient drug development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115957143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115957143","market":"sg","top_or_hot":-1,"title":"Stock Track | INSILICO Soars 5% in Intraday Trading Following Successful HKEX IPO","media":"Stock Track","content":"<p>Insilico Medicine (03696.HK) saw its stock price surge by 5.00% during intraday trading on Wednesday, reflecting strong investor enthusiasm following its successful listing on the Hong Kong Stock Exchange (HKEX). The IPO, the largest biotech offering on HKEX in 2025, has positioned the company as a leader in AI-driven drug discovery.</p><p>The company's shares opened at HK$35.00, significantly above its issue price of HK$24.05, signaling robust market confidence. Insilico Medicine's innovative Pharma.AI platform and partnerships with top pharmaceutical firms, including Sanofi and Lilly, have further bolstered investor sentiment. The IPO has provided the company with additional resources to advance its mission of leveraging AI for faster and more efficient drug development.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | INSILICO Soars 5% in Intraday Trading Following Successful HKEX IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | INSILICO Soars 5% in Intraday Trading Following Successful HKEX IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-31 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Insilico Medicine (03696.HK) saw its stock price surge by 5.00% during intraday trading on Wednesday, reflecting strong investor enthusiasm following its successful listing on the Hong Kong Stock Exchange (HKEX). The IPO, the largest biotech offering on HKEX in 2025, has positioned the company as a leader in AI-driven drug discovery.</p><p>The company's shares opened at HK$35.00, significantly above its issue price of HK$24.05, signaling robust market confidence. Insilico Medicine's innovative Pharma.AI platform and partnerships with top pharmaceutical firms, including Sanofi and Lilly, have further bolstered investor sentiment. The IPO has provided the company with additional resources to advance its mission of leveraging AI for faster and more efficient drug development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1115957143","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115957143","pubTimestamp":1767144798,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Insilico Medicine (03696.HK) saw its stock price surge by 5.00% during intraday trading on Wednesday, reflecting strong investor enthusiasm following its successful listing on the Hong Kong Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"个股追踪|INSILICO港交所IPO成功后盘中大涨5%","themeId":"3800b70a39b2b6017b3a0f21f56e5031","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine (03696.HK) saw its stock price surge by 5.00% during intraday trading on Wednesday, reflecting strong investor enthusiasm following its successful listing on the Hong Kong Stock Exchange (HKEX). The IPO, the largest biotech offering on HKEX in 2025, has positioned the company as a leader in AI-driven drug discovery.The company's shares opened at HK$35.00, significantly above its issue price of HK$24.05, signaling robust market confidence. Insilico Medicine's innovative Pharma.AI platform and partnerships with top pharmaceutical firms, including Sanofi and Lilly, have further bolstered investor sentiment. The IPO has provided the company with additional resources to advance its mission of leveraging AI for faster and more efficient drug development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115957143","isCrawlerRequest":true}